Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13

Climb Bio, Inc. (NASDAQ: CLYM) reported Q3 EPS of ($0.13), versus $0.00 reported last year.

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Rockstar Energy founder seeks CEO role at Celsius Holdings
• Minerva Neurosciences (NERV) Tops Q2 EPS by 5c
• Claude: Auto mode is now the default in Claude Code for Pro, Max, and Team plans